Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Understanding unexplained heart failure in patients with liver cirrhosis

Understanding unexplained heart failure in patients with liver cirrhosis

Date time 13 January, 2022
News Type News type Research News

The Centenary Institute’s Dr Madeleine Gill has today received a National Health and Medical Research Council (NHMRC) postgraduate scholarships grant to continue her research into understanding unexplained heart failure in patients with liver cirrhosis.

Cirrhotic cardiomyopathy affects approximately 50 per cent of patients with cirrhosis and can be a barrier to liver transplantation and is associated with new cardiovascular disease.

“This research aims to enrich our understanding of how often, and why cirrhotic cardiomyopathy happens, using a new technique called ‘metabolomics’ to look for specific bloods markers and follow the changes in patients’ hearts before and after transplant,” said Dr Gill.

The NHMRC postgraduate scholarships will create opportunities for many graduates in medicine and health sciences to pursue their ideas and tackle the health challenges facing our community.

Further information on the grants visit the NHMRC website.

Themes

  • Cancer Innovations

    Cancer Innovations

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • New laboratories strengthen Centenary Institute research

    The Centenary Institute has established four new research laboratories, broadening its capabilities across the areas of infection and immunity, respiratory disease and biomedical artificial intelligence (AI).
    News Type: Media release
    Date 20 Oct 2026
  • Scholarships awarded to support rare disease and cancer research

    Two Centenary Institute researchers have received scholarship funding to support work exploring new approaches to understanding inflammation and the immune system, with the aim of improving disease treatment.
    News Type: Research News
    Date 24 Sep 2026
  • Modified BCG vaccine strengthens protection against TB

    Researchers from the Centenary Institute and the University of Sydney have developed a modified version of the tuberculosis (TB) vaccine BCG that provided stronger and more sustained protection against TB. In preclinical tests in mice, the modified vaccine showed potential as a new approach to improving the effectiveness of TB vaccination. A bacterial infection caused ...
    News Type: Media release
    Date 15 Sep 2026
  • When Art Meets Science – People’s Choice and Staff Pick winners

    The winners of the People’s Choice and Staff Pick categories in the Centenary Institute’s ‘When Art Meets Science’ Prize have been announced, celebrating two striking scientific images that reveal the hidden detail and complexity of medical research.
    News Type: Community
    Date 02 Sep 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram